home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stem Cells And Leukaemia

  April, 26 2006 9:29
your information resource in human molecular genetics
One of the many jobs of haematopoietic stem cells is to keep in balance the normal expansion of cell numbers in the bone marrow without creating an overabundance of cells that may lead to leukaemia. A tipping point of this fine balance may have been found in a signalling molecule known as phosphatase and tensin homologue, or PTEN.

In a study to be published online by Nature, Linheng Li and colleagues show that this molecule, which normally keeps in check the phosphatidylinositol-3-OH kinase (PI(3)K) proliferation pathway, is crucial in this process. The researchers placed bone marrow stem cells containing an inactive form of PTEN into recipient mice and found that these mutant cells generated more myeloid and T-lymphoid cells, mimicking the onset of myeloid and lymphoid leukaemia.

Pinpointing the difference between leukaemic stem cells and haematopoietic stem cells with molecules such as PTEN may one day lead to more targeted therapies that can better distinguish between cancer and normal stem cells.

Author contact

Linheng Li (Stowers Inst for Medical Research, Kansas City, MO USA)
E-mail: lil@stowers-institute.org

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.